Online ISSN: 2515-8260

Keywords : susceptibility

The burden of Staphylococcus aureus infections at medicine department, IMS and SUM Hospital, Bhubaneswar

Sarada Prasad Sahu, Asish Malla, Dr. Debasmita Tripathy, Rajesh Kumar Lenka

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1940-1944

Background: Staphylococcus aureus infections are one of the major infections in hospitals and the drug-resistant strain of S. aureus caused mortality and morbidity throughout the globe. In this study, we evaluated the S. aureus infection and their drug sensitivity patterns at Medicine department for 5 years.
Methods: The patients admitted at medicine word were participated in this study. All clinical samples were taken for bacteriological study. After identification of bacteria, the drug sensitivity patterns were carried out by disc diffusion methods.
Results: A total of 944 S. aureus isolates were analyzed. High sensitivity of S. aureus was observed for quinupristin/dalfopristin (100%), tigecycline (98.2), imipenem (98%), nitrofurantoin (97.6%), linezolid (97.3%), teicoplanin (97.1%) and vancomycin (95.1%). High resistance was recorded against penicillin G (91.9%), trimethoprim/sulfamethoxazole (56.9%) and tetracycline (33.2%). MRSA prevalence among the patients at IMS and SUM Hospital, Bhubaneswar was 27.8%. Highest proportion (80%) of MRSA was in burns unit.
Conclusions: Both MRSA and MSSA were highly susceptible to quinupristin/dalfopristin, tigecycline, linezolid, nitrofurantoin, ampicillin/sulbactam and vancomycin and showed high resistance to commonly used antibiotics such as gentamycin, erythromycin, levofloxacin and tetracycline. A majority of isolates were from pus specimen (68%).

Prevalence Of ABO Blood Groups And Its Susceptibility To Covid 19 Patients In A Tertiary Care Centre Located In A Tropical Region – A Retrospective Study: A Subject To Ponder!

Dr. A. Hariharan; Dr. I. Sureshkumar; Dr. N.V. Hemamalini; Dr. Vinod Kumar Panicker

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 3553-3557

The extensive spread of novel coronavirus19 (COVID19) had put a tremendous burden on health care facilities in investigation and prioritizing the treatment of COVID19 patients. Globally, as of 21 October 2020, there have been 40,455,651 confirmed cases of COVID-19, including 1,119,431 deaths, reported to WHO.Due to rapid increase in its alarmist state it is of prime importance to assess the factors influencing the COVID19 susceptibility. In our study we assessed one of the independent factors like blood group in COVID19 patients. We conducted a retrospective analysis to assess the prevalence and distribution of blood group among COVID19 patients in order to determine its susceptibility. In our study we assessed1000 COVID19 patients and their blood group was traced in order to find their distribution. In our study majority of COVID19 patients belong to A group and the least belongs to O and AB group. Although a detailed analysis is required for determining the association between blood group and COVID19 susceptibility, these data can throw light and form the basement for a future extensive study.